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IFI27 is an interferon a-inducible protein found to be upregulated in lesional and non-lesional psoriatic skin in a
gene array study. To further characterize its function, we studied by in situ hybridization whether IFI27 is expressed
in psoriasis, other inﬂammatory skin diseases, and wound repair in vivo. We also examined its regulation by
different growth factors and anti-psoriatic agents using quantitative RT-PCR (TaqMan). IFI27 mRNA expression was
highly upregulated in lesional psoriatic epidermis and also detected in non-lesional keratinocytes. It was also
expressed in lichen planus, chronic eczema, cutaneous squamous cell cancers, and during normal wound repair
when IFI27 was found in the proliferating subpopulation of keratinocytes. A 3–17-fold upregulation of IFI27 mRNA
expression was observed when keratinocytes were stimulated with IFN-c, TNF-a, or TGF-b1 while retinoids and
vitamin D downregulated its expression. Our results suggest that IFI27 is a novel marker of epithelial proliferation
and cancer.
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Interferons exert their biological function mainly through the
activation of interferon-stimulated genes (ISG). IFI27 (also
known as ISG12 or p27) belongs to a family of small,
interferon-alpha (IFN-a)-inducible genes of unknown func-
tion. The cDNA for IFI27 was originally cloned as an
estrogen-inducible gene in the human epithelial cell line
MCF-7 and designated as p27 (Rasmussen et al, 1993). In
several types of cell lines (B-lymphoid, cervical and breast
epithelial, SV40-transformed keratinocytes, and fibroblasts)
IFI27 is strongly induced by IFN-a and to a lower extent by
IFN-gamma (IFN-g) as assessed by RT-PCR (Gjermandsen
et al, 2000). Immunohistochemical analyses reveal that
upon treatment of HeLa cells with IFN-a, the IFI27 gene
product resides in the nuclear envelope. IFI27 is thus the
first interferon-induced protein that localizes to this site
(Martensen et al, 2001).
Psoriatic keratinocytes elaborate IFN-g (Ortonne et al,
1999) and injection of this cytokine into healthy skin results
in a psoriasis-like skin reaction (Barker et al, 1993). This is
likely to be mediated in part by the expression of the type I
cytokines such as tumor necrosis factor alpha (TNF-a)
(Austin et al, 1999). IFI27 mRNA was recently found to be
upregulated 13-fold in lesional and 10-fold in uninvolved
skin compared to normal skin in an extensive gene array
study (Bowcock et al, 2001). IFI27 maps to chromosome
14q32, a region where a putative psoriasis susceptibility
locus has been found in several studies (Bowcock et al,
2001; Veal et al, 2001). The aim of this study was to examine
the expression pattern and regulation of IFI27 in skin with
special emphasis on psoriasis, other inflammatory skin
diseases, and wound repair. In the course of this study,
we also investigated a variety of epithelial cancers and
demonstrated upregulation of IFI27 in a subset of them. We
observed that IFI27 is a marker of epithelial proliferation and
cancer.
Results
To investigate the expression pattern and regulation of IFI27
in skin with special emphasis on psoriasis and other
inflammatory skin diseases, we first performed northern
analyses of keratinocyte and fibroblast cultures. IFI27
mRNA could not be detected in fibroblasts (data not
shown), whereas it was detected in many keratinocyte cell
lines from psoriasis patients and carriers (Fig 1a). Interest-
ingly, IFI27 expression levels varied considerably in different
keratinocyte lines (Fig 1a) and treatment of keratinocytes
with TNF-a increased IFI27 levels by approximately 2-fold
(Fig 1a). Primary human keratinocytes from several normal
individuals, cultured as previously described (Suomela et al,
2003), were then treated with various cytokines and IFI27
expression was investigated with quantitative Taqman RT-
PCR (Rechardt et al, 2000). Its expression was not modified
by LPS, PMA, IL-1b, EGF, TGF-a, KGF, bFGF, VEGF, IL-10,
or IGF-1; however, IFN-g, TNF-a, and TGF-b1 all upregu-
lated IFI27 expression 3–17-fold (Fig 1b), in agreement with
the northern analyses. Upregulation of IFI27 by TNF-a was
more pronounced when the cells were stimulated for 48 h
(16-fold) compared to 24 h (8-fold). Of the agents used for
Abbreviations: SCC, squamous cell cancer; TNF-a, tumor necrosis
factor alpha
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the therapy of psoriasis, retinoic acid and vitamin D
downregulated IFI27 expression (expression level 26%–
44% of the untreated control) (Fig 1c), whereas dexametha-
sone showed no effect.
IFI27 was abundantly expressed in psoriatic skin (Fig
2a,b,e), in agreement with previous gene array data
(Bowcock et al, 2001). In situ hybridization also revealed
expression of IFI27 in non-lesional skin, although the signal
was lower (Fig 2e). Normal skin (Fig 2d ) did not express
IFI27 in accordance with previous RT-PCR findings (Ras-
mussen et al, 1993). Despite the different clinical treatments
used prior to biopsy, the level of signal was roughly equal in
all specimens of lesional skin. In situ hybridization, however,
is a qualitative and not a quantitative technique, and there
could have been differences that were not detected.
IFI27 mRNA was also detected in the epidermis of
patients with chronic eczema (three of three), lichen planus
(three of three), and lichenoid dermatitis (three of four) (Fig
2f ). Two diseases, however, representing differential diag-
noses of psoriasis, palmoplantar pustulosis and pityriasis
rubra pilaris, were negative (data not shown). Chronic
venous ulcers were devoid of IFI27 mRNA, whereas
normally healing wounds from pinch graft sites at the upper
thigh (Vaalamo et al, 1996) expressed IFI27. The signal was
present at the areas of proliferating keratinocytes since
migrating cells, showing strong cytoplasmic laminin-5
staining (Rechardt et al, 2000), were not positive (Fig 2g–l ).
The number of IFI27 positive cells clearly increased from 1-
to 9-d wounds (Fig 2g–l ). Basal cell cancers lacked IFI27
mRNA (data not shown), although 9 of 13 SCC, representing
grades I–III, were strongly positive (Fig 2m). Thus, the
degree of differentiation of the tumor did not seem to
influence its expression. No signal was detected with the
sense probe.
Discussion
Our present results confirm that whereas IFI27 mRNA
cannot be detected in normal skin, it is highly upregulated in
involved skin and is also detected in uninvolved psoriatic
skin (Bowcock et al, 2001). IFI27 mRNA was also detected
in many benign skin disorders characterized by keratinocyte
hyperproliferation such as hypertrophic lichen planus and
chronic eczema. This overexpression may well be mediated
through IFN-g, which is elaborated by keratinocytes of both
lichen planus and psoriasis (Fayyazi et al, 1999; Ortonne,
1999). Furthermore, elevated IFN-g levels have been linked
to eczema both in vitro and in vivo (Carroll et al, 1997).
Figure 1
IFI27 is variably expressed in keratinocyte lines by northern analysis and upregulated by IFN-c, TNF-a and TGF–b1 and downregulated by
retinoic acid (RA) and vitamin D as assessed by quantitative real-time PCR. (a) Northern analysis of IFI27 in keratinocyte lines reveals variable
levels of expression and upregulation following TNF-a treatment. Keratinocyte lines from psoriasis patients K1-1, K25-6, K5-14, K21-2 and psoriasis
carriers from multiply affected families (K21-1 and K22-2). Cultures were split and TNF-a was added to one half of the culture at 10 ng per mL: 
(control lines), þ (treated lines). The size of the major IFI27 transcript is indicated. Beneath the autoradiograph of the northern is an agarose gel
showing the quantity and integrity of the RNA used to prepare the northern blot. (b) Relative expression of IFI27 in normal and stimulated
keratinocytes assessed by quantitative, real-time PCR. Keratinocytes were cultured in KGM. Total RNA was isolated and reverse transcribed to
cDNA. TaqMan was performed as described in Materials and Methods using 18S RNA as an endogenous control. Results are shown relative to
mRNA levels from nonstimulated normal keratinocytes, assigned the value 1. IFI27 was upregulated by IFN-g, TNF-a (after 24 h and 48 h
stimulation), and TGF-b1. (c) IFI27 expression was downregulated by RA and vitamin D in primary keratinocytes cultured and assessed by Taqman
as described above.
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There have been previous reports of IFI27 expression in
other tissues such as colon, stomach, and lung (Rasmussen
et al, 1993). We observed that IFI27 is upregulated during
normal skin repair, but that IFI27 mRNA is not detected in
chronic wounds that have existed more than 3 mo. This may
reflect the fact that the cytokine profile (e.g., levels of active
TNF-a and IFN-g) and the composition of the inflammatory
cell infiltrates of the chronic wound environment are very
different from re-epithelializing wounds (Hu¨bner et al, 1996;
Loots et al, 1998). Based on our serial specimens,
keratinocytes expressing IFI27 did not seem to be migratory
but rather located in the zone of proliferating keratinocytes.
Our results suggest that IFI27 is temporarily and spatially
regulated during wound repair as is the case with IP-10 (IFN-
g-inducible protein 10) and Mig (monokine induced by IFN-
g), two other proteins reported to be upregulated in psoriasis
(Engelhardt et al, 1998; Gillitzer and Goebeler, 2001). This
reflects the features of proliferating keratinocytes in psoriasis
that are reminiscent of the second phase of normal re-
epithelialization. At this stage, one finds proliferation of the
subadjacent keratinocytes after migration has taken place.
IFI27 was also strongly expressed in a subpopulation of
SCC, unlike in BCC, which may reflect their histopatholo-
gical differences and the higher proliferation index of SCC
(al-Sader et al, 1996). IFI27 may therefore be a marker of
certain epithelial cancers.
In keratinocyte cultures, IFI27 was upregulated by IFN-g,
TNF-a, and TGF-b1. These are all cytokines known to inhibit
keratinocyte proliferation in vitro (Symington, 1989). This dis-
crepancy may be explained by the fact that many cytokines
have different effects on keratinocytes in vivo and in culture
(Turksen et al, 1992). In a previous study, TNF-a, GM-CSF,
and EGF did not upregulate IFI27 in SV40-transformed
human keratinocytes (Gjermandsen et al, 2000). Further-
more, IFN-g-induced IFI27 upregulation was much lower
than in this study (3-fold vs 17-fold). We however observed
upregulation of IFI27 in keratinocytes immortalized with E6/
E7 viral proteins. These discrepant results may reflect the
fact that primary keratinocytes are in many aspects different
from immortalized SV40-transformed cells (Celis and Olsen,
1994).
TNF-a is a multifunctional cytokine that is induced by
inflammation and is found in psoriatic lesions (Ortonne,
1999). Our results suggest that together with IFN-g, it may
Figure 2
In situ hybridization reveals that IFI27
is expressed in the epithelia of pa-
tients with psoriasis, lichen planus,
and squamous cell carcinoma. (a)
Dark-field image for IFI27 mRNA in an
untreated psoriatic lesion displaying
abundant signal in keratinocytes. (b)
The corresponding bright-field image.
(c) A parallel section hybridized with a
sense cRNA probe for IFI27 is devoid of
signal. (d ) Normal skin expresses no
signal for IFI27. (e) Another psoriasis
sample expressing the border area
between lesional and non-lesional skin.
The positive signal in non-lesional skin is
marked but not as strong as in lesional
skin. The arrow depicts the border
between the non-lesional and lesional
skin. (f ) A strong signal is also seen in a
sample of hypertrophic lichen planus. (g)
No signal for IFI27 mRNA in a 1-d acute
wound where laminin-5 immunostaining
reveals numerous migrating cells in an
adjacent section ( j). (h) In a 6-d wound,
hyperproliferative keratinocytes are po-
sitive in an area, where laminin-5 stain-
ing is diminishing (k). (i ) In a 9-d acute
wound, IFI27 mRNA is seen in hyper-
proliferative keratinocytes, while lami-
nin-5 staining is still weaker and
concentrates along the basement mem-
brane (l ). Arrows depict corresponding
areas. (m) Signal for IFI27 mRNA in an
SCC. (n) Corresponding bright-field im-
age. Scale bars: (e,f ) 125 mm, (a,c,g–n)
50 mm, (b,d) 25 mm.
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be upregulating IFI27 expression in psoriatic skin. Retinoids
and vitamin D downregulated IFI27 expression in keratino-
cytes, suggesting that as psoriasis heals during oral or
topical therapy, IFI27 expression ceases in keratinocytes. It
is possible that novel TNF-a antagonist drugs may exert
their beneficial effects partly via pathways, in which IFI27
is involved. In fact, their use might also slow down the
growth of SCC through inhibition of IFI27. In summary, IFI27
appears to be a novel marker of epithelial proliferation and
cancer.
Materials and Methods
Northern analyses Keratinocytes were cultured in keratinocyte
growth medium (KGM) supplemented with epidermal growth factor
(EGF) and bovine pituitary extract (BPE) until confluency. The cells
were then washed twice with PBS and transferred to keratinocyte
basic medium without supplementary nutrients. Cultures were split
and TNF-a was added to one half of the culture at 10 ng per mL.
After 24 h, total cellular RNA was extracted with TRIzol reagent
according to the manufacturer’s instructions (Invitrogen, Carlsbad,
California). Primary fibroblast cultures from psoriatic and normal skin
were established with routine methods, cells were harvested, and
RNA was prepared. Total RNA was denatured and separated on 1%
agarose gel containing 2.2% formaldehyde, and transferred to nylon-
supported nitrocellulose membrane (Osmonics, Massachusetts). A
482 bp fragment of human IFI27 cDNA was labeled with [a-32P]dCTP.
Hybridization was performed with PerfectHyb Plus buffer according
to the procedure provided by the manufacturer (Sigma, St Louis,
Missouri). Hybridization signal was detected by autoradiography.
Cell cultures, cytokines and growth factors Keratinocytes were
cultured in KGM supplemented with EGF and BPE, equal numbers
were plated on 24-well tissue culture plates, and the next day the
cells were incubated in KGM without supplements for 18–24 h. The
cells were subsequently treated with phorbol 12-myristate 13-
acetate (PMA, 10 ng per mL, Sigma), interleukin-1 beta (IL-1b, 5 U
per mL, Roche Molecular Biochemicals, Mannheim, Germany),
IFN-g (100 U per mL, Roche), transforming growth factor alpha
(TGF-a, 30 ng per mL, Sigma), keratinocyte growth factor (KGF, 10
ng per mL, Sigma), EGF (10 ng per mL, Sigma), insulin-like growth
factor-1 (IGF-1, 100 ng per mL, R & D Systems, Minneapolis,
Minneapolis), basic fibroblast growth factor (bFGF, 10 ng per mL,
Sigma), TNF-a (10 ng per mL, Sigma), transforming growth factor
beta-1 (TGF-b1, 10 ng per mL, Sigma), vascular endothelial growth
factor (VEGF, 10 ng per mL, R & D Systems), lipopolysaccharide
(LPS, 2,5 mg per mL, Sigma), retinoic acid (RA, 106 M, Sigma),
interleukin-10 (IL-10, 10 ng per mL, R & D Systems), dexametha-
sone (105 M, Sigma), or 1,25-(OH)2 D3 (calcitriol, 10
7 M, Sigma).
Untreated cells were used as controls. After 24 and 48 h, total RNA
was extracted from the cells using an RNeasy miniprep-kit
(Qiagen, Chatsworth, California), and reverse transcribed to
complementary DNA with Taqman Reverse Transcription reagents
(Applied Biosystems, Foster City, California) with random hexam-
ers and used as a template for TaqMan quantitative, real-time PCR.
PCR primers and probes and quantitative real-time PCR
(TaqMan RT-PCR) PCR primers and probes (Applied Biosystems)
for IFI27 were designed with the computer program Primer Express
1.5 (Applied Biosystems). Primers used for the amplification were
TGC CTC GGG CAG CCT (forward nucleotides) and TTG GTC AAT
CCG GAG AGT CC (reverse nucleotides). Human 18S RNA labeled
with VICTM reporter dye (pre-developed TaqMan assay reagents for
endogenous control human 18S RNA, Applied Biosystems) was
used as an endogenous control. Reactions were performed with
the ABI PRISM 7700 Sequence Detector System (Applied
Biosystems) in 20 mL volumes, IFI27 and 18S RNA in separate
reactions. For IFI27 the mixture contained 5 mL 1:5 diluted cDNA,
100 nM of each primer, and 200 nM of the FAM-labeled probe. For
18S RNA the mix contained 1 mL 18S RNA control reagents, 5 mL of
the diluted cDNA, and 1  Taqman Universal Master Mix. The PCR
was started with 2 min at 501C and an initial 10 min denaturation at
941C, followed by a total of 40 cycles of 15 s denaturation at 941C,
and 1 min of annealing and elongation at 601C.
Tissues Formalin-fixed, paraffin-embedded specimens were ob-
tained from the Department of Dermatopathology, University of
Helsinki. in compliance with Declaration of Helsinki guidelines.
Informed consent was obtained from each patient prior to the
biopsy of psoriatic skin. The study protocol was approved by the
corresponding Ethical Committee. Twenty-three patients affected
with psoriasis (duration of disease from newly diagnosed to several
decades) were included in this study and biopsies were taken
from the center of psoriatic lesions. Twelve of the patients were
untreated, five used topical corticosteroids, two used topical
calcipotriol, two used topical corticosteroids þ calcipotriol, one
used SUP and one was subjected to PUVA treatment. Biopsies
from 16 of these patients were also taken from the normal-looking
skin approximately 10 cm away from the psoriasis lesion or
from the border between lesional and non-lesional skin. Spe-
cimens of lichen planus (n¼ 3), lichenoid chronic dermatitis
(¼ neurodermatitis) (n¼ 3), palmoplantar pustulosis (n¼ 3), pityr-
iasis rubra pilaris (n¼ 3), chronic eczema (n¼ 3), squamous cell
cancers (SCC) of different grades (n¼ 13), basal cell cancers
(n¼ 4), chronic wounds (n¼ 5), normally healing timed wounds
(n¼ 6) (Vaalamo et al, 1996), and normal skin (n¼ 6) were also
examined by in situ hybridization.
In situ hybridization A 482 bp cDNA fragment of IFI27 was
amplified with the PCR and subcloned into pBluescript SKþ
plasmid digested with EcoRI/BamHI. The insert was released with
PvuII and its integrity was confirmed by DNA sequencing. The
sense probe was transcribed as a T7 run-off. T3 was used
for the antisense probe. Transcription of the sense and antisense
probes has been described elsewhere (Saarialho-Kere et al,
1994). In situ hybridization was performed on 5 mm sections as
described in detail (Prosser et al, 1989). Sections were hybridized
with 35S-labeled probes (3.5  104 cpm per mL of hybridization
buffer) at 551C for at least 18 h in a humidified chamber.
After 10–29 d of autoradiography, the photographic emulsion
was developed, and the slides were stained with hematoxylin and
eosin. No signal was detected with the sense probe. The
slides were analyzed independently by two investigators (U.S.-K.
and S.S.).
Immunohistochemistry Migrating keratinocytes demonstrating
strong cytoplasmic staining for laminin-5 were identified with
polyclonal rabbit antibodies against the g2 chain of laminin-5
(1:600, a gift from Professor Karl Tryggvason, Karolinska Institutet)
as previously described (Saarialho-Kere et al, 2002). Diaminoethyl-
carbazole was used as chromogenic substrate and hematoxylin as
counterstain.
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